Psychotropic drug–related weight gain (PDWG) is a common occurrence and is highly
associated with non-initiation, discontinuation, and dissatisfaction with psychiatric drugs …

Introduction The roles of metabolic signals, including Glucagon-like peptide 1 (GLP-1), have
been implicated in multiple domains outside metabolic regulation. There is a growing …

G protein-coupled receptors (GPCRs) are important, potential drug targets for the treatment
of metabolic disorders, such as obesity. GPCRs crosstalk with several transducers, including …

The surge in popularity of semaglutide (Ozempic, Wegovy, Rybelsus) and other glucagon-
like-peptide 1 (GLP-1) receptor agonists has been accompanied by widespread reports of …

The use of glucagon-like peptide-1 (GLP-1) receptor-based multi-agonists in the treatment of
type 2 diabetes and obesity holds great promise for improving glycaemic control and weight …

Cordyceps sinensis (CS) has been widely used as a dietary supplement or traditional
medicine for the prevention, treatment, and prognostication of various diseases, because of …

Abstract The glucagon-like peptide-1 (GLP-1) receptor, known as GLP-1R, is a vital
component of the G protein-coupled receptor (GPCR) family and is found primarily on the …

Reinforcement learning (RL) refers to the ability to learn stimulus-response or response-
outcome associations relevant to the acquisition of behavioral repertoire and adaptation to …

The use of NPS compounds is increasing, and impairment in spatial learning and memory is
a growing concern. Alpha-pyrrolidinovalerophenone (α-PVP) consumption, as a commonly …

Associative learning can drive many different types of behaviors, including food
consumption. Previous studies have shown that cues paired with food delivery while mice …